These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Clinical perspectives of concepts on neoplastic stem cells and stem cell-resistance in chronic myeloid leukemia. Valent P; Deininger M Leuk Lymphoma; 2008 Apr; 49(4):604-9. PubMed ID: 18398718 [TBL] [Abstract][Full Text] [Related]
30. Efficacy of tyrosine kinase inhibitors on a mouse chronic myeloid leukemia model and chronic myeloid leukemia stem cells. Tanaka Y; Fukushima T; Mikami K; Adachi K; Fukuyama T; Goyama S; Kitamura T Exp Hematol; 2020 Oct; 90():46-51.e2. PubMed ID: 32910995 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of autophagy: a new strategy to enhance sensitivity of chronic myeloid leukemia stem cells to tyrosine kinase inhibitors. Calabretta B; Salomoni P Leuk Lymphoma; 2011 Feb; 52 Suppl 1(Suppl 1):54-9. PubMed ID: 21250825 [TBL] [Abstract][Full Text] [Related]
32. Autophagy and mitochondrial metabolism: insights into their role and therapeutic potential in chronic myeloid leukaemia. Baquero P; Dawson A; Helgason GV FEBS J; 2019 Apr; 286(7):1271-1283. PubMed ID: 30222247 [TBL] [Abstract][Full Text] [Related]
33. Suppression of autophagy by BCR/ABL. Calabretta B; Salomoni P Front Biosci (Schol Ed); 2012 Jan; 4(2):453-60. PubMed ID: 22202070 [TBL] [Abstract][Full Text] [Related]
34. Enhanced targeting of CML stem and progenitor cells by inhibition of porcupine acyltransferase in combination with TKI. Agarwal P; Zhang B; Ho Y; Cook A; Li L; Mikhail FM; Wang Y; McLaughlin ME; Bhatia R Blood; 2017 Feb; 129(8):1008-1020. PubMed ID: 28011678 [TBL] [Abstract][Full Text] [Related]
35. Therapeutic inhibition of FcγRIIb signaling targets leukemic stem cells in chronic myeloid leukemia. Parting O; Langer S; Kuepper MK; Wessling C; Li S; Braunschweig T; Chatain N; Maié T; Costa IG; Crysandt M; Huber M; Brümmendorf TH; Koschmieder S; Schemionek M Leukemia; 2020 Oct; 34(10):2635-2647. PubMed ID: 32684632 [TBL] [Abstract][Full Text] [Related]
36. The Impact of Tyrosine Kinase Inhibitors on Chronic Myeloid Leukemia Stem Cells and the Implication in Discontinuation. Jiang L; Wang H; Zhu X; Liu W; Zhou S; Geng Z; Xiao Y; Zou P; You Y; Li Q; Zhu X Stem Cells Dev; 2019 Nov; 28(22):1480-1485. PubMed ID: 31530245 [TBL] [Abstract][Full Text] [Related]
37. Targeting BMP signaling in the bone marrow microenvironment of myeloid leukemia. Lefort S; Maguer-Satta V Biochem Soc Trans; 2020 Apr; 48(2):411-418. PubMed ID: 32167132 [TBL] [Abstract][Full Text] [Related]